Proteomic biomarkers of heart failure FINAL.pdf (683.4 kB)
Download fileProteomic biomarkers of heart failure
journal contribution
posted on 2018-06-04, 13:40 authored by M. Zubair Israr, Liam HeaneyLiam Heaney, Toru SuzukiHeart failure (HF) is associated with significant morbidity and mortality. Biomarkers are used to assist clinicians with timely diagnosis, prognosis and risk prediction of patients for
personalized treatment. Using modern proteomic methods such as mass spectrometry, an increasing number of novel biomarkers have been identified that further aid clinicians in the early diagnosis and outcome prediction of HF. This review focuses on the array of common
and novel protein-based biomarkers which provide diagnostic and prognostic information in HF.
History
School
- Sport, Exercise and Health Sciences
Published in
Heart Failure ClinicsVolume
14Issue
1Pages
93 - 107Citation
ISRAR, M.Z., HEANEY, L.M. and SUZUKI, T., 2018. Proteomic biomarkers of heart failure. Heart Failure Clinics, 14(1), pp. 93-107.Publisher
© ElsevierVersion
- AM (Accepted Manuscript)
Publisher statement
This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/Acceptance date
2017-09-01Publication date
2018Notes
This paper was accepted for publication in the journal Heart Failure Clinics and the definitive published version is available at https://doi.org/10.1016/j.hfc.2017.08.010ISSN
1551-7136Publisher version
Language
- en